Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.92
-0.4%
$0.95
$0.58
$1.39
$71.89M0.93127,855 shs411 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.60
+1.8%
$2.53
$2.07
$3.80
$79.50M0.6251,002 shs39,622 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.22
-3.1%
$1.54
$0.53
$4.49
$20.87M4.671.24 million shs27,900 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.79
-0.8%
$4.62
$4.01
$9.33
$78.77M1.3202,835 shs3,924 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-2.65%-5.45%-15.60%-9.80%+19.95%
InspireMD, Inc. stock logo
NSPR
InspireMD
+0.39%+2.41%-5.56%-12.07%-3.41%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+3.28%+4.13%-29.61%-48.15%+75.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+2.33%+0.21%+11.55%+2.99%-12.18%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
2.8744 of 5 stars
3.55.00.00.01.92.50.0
InspireMD, Inc. stock logo
NSPR
InspireMD
2.837 of 5 stars
3.55.00.00.00.62.50.6
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.4151 of 5 stars
3.55.00.00.03.23.30.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.0687 of 5 stars
3.61.00.00.02.70.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.2536.46% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5073.41% Upside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00309.50% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67143.56% Upside

Current Analyst Ratings Breakdown

Latest NXL, MLSS, NSPR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/24/2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$5.00
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$8.61M8.35N/AN/A$0.11 per share8.33
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M11.31N/AN/A$1.83 per share1.42
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$131.07K160.03N/AN/A$0.43 per share2.84
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M1.99$0.05 per share96.29$2.98 per share1.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.07N/AN/A-52.01%-60.26%-40.23%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65M-$0.83N/AN/A-3,407.98%-187.59%-167.21%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1011.9820.83N/A15.90%12.60%11.38%8/14/2025 (Estimated)

Latest NXL, MLSS, NSPR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
3/14/2025Q4 2024
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A-$0.28N/A-$0.28N/A$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
16.42
15.89
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89

Institutional Ownership

CompanyInstitutional Ownership
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
24.75%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
24.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3078.48 million58.61 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million10.11 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.92 0.00 (-0.43%)
As of 10:45 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.60 +0.05 (+1.76%)
As of 10:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.22 -0.04 (-3.10%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.79 -0.04 (-0.83%)
As of 10:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.